Skip to content
Screener

Gossamer Bio, Inc. GOSS Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$13.3MBeat by $5.8M
EPS-$0.21Miss by $0.02
Revenue estimate$7.5M
EPS estimate-$0.19

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$10.7M
EPS estimate-$3.81

FAQ

When did Gossamer Bio, Inc. report Q3 2025 earnings?
Gossamer Bio, Inc. (GOSS) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Gossamer Bio, Inc.'s Q3 2025 revenue and EPS?
Gossamer Bio, Inc. reported revenue of $13.3M and eps of $-0.21 for Q3 2025.
Did Gossamer Bio, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $7.5M by $5.8M. EPS missed the consensus estimate of $-0.19 by $0.02.
How did Gossamer Bio, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 40.2% from $9.5M a year earlier and eps declined 50.0% from $-0.14.
Where can I find Gossamer Bio, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001728117-25-000082) and the 10-Q periodic report (0001728117-25-000081) directly on SEC EDGAR. The filing index links above go to sec.gov.